Trial Profile
Effect of repetitive levosimendan treatment on clinical outcomes of chronic heart failure patients: focus on optimal patient selection based on novel cardiac biomarkers.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2017
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Heart failure; Myocardial ischaemia
- Focus Therapeutic Use
- 20 Feb 2017 New trial record